SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-332378
Filing Date
2012-08-03
Accepted
2012-08-02 18:02:04
Documents
8
Period of Report
2012-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d389940d8k.htm 8-K 18487
2 UNDERWRITING AGREEMENT d389940dex11.htm EX-1.1 171901
3 OPINION OF WILMER CUTLER PICKERING HALE AND DORR LLP d389940dex51.htm EX-5.1 10739
4 PRESS RELEASE d389940dex991.htm EX-99.1 5127
5 GRAPHIC g3899401_image.jpg GRAPHIC 2745
6 GRAPHIC g389940g11w49.jpg GRAPHIC 6481
7 GRAPHIC g389940g16y82.jpg GRAPHIC 1830
8 GRAPHIC g389940g47i62.jpg GRAPHIC 4336
  Complete submission text file 0001193125-12-332378.txt   229287
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-49839 | Film No.: 121004723
SIC: 2834 Pharmaceutical Preparations